A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy Volunteers
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This is an open label, randomized, single dose, one cohort, two sequence, two period
crossover study in healthy subjects. The primary objective of the study is to evaluate the
effect of a single oral dose of aprepitant on the pharmacokinetic (PK) profile of a single
oral dose of bosutinib in healthy subjects.